Streetbeat News

Analyst Ratings

SOFI

SoFi Technologies shares are trading lower after Oppenheimer downgraded the stock to Perform rating from Outperform.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 10:44 am

ESPR

Esperion Therapeutics' stock has been upgraded to Buy from Underperform by BofA Securities, with the price target raised from $1.25 to $4.

Portfolio Pulse from Benzinga Newsdesk

June 15, 2023 | 10:37 am

OMF

B of A Securities analyst Kenneth Bruce initiates coverage on OneMain Holdings (NYSE:OMF) with a Buy rating and a price target of $49.

Portfolio Pulse from richadhand@benzinga.com

June 15, 2023 | 10:27 am

TGLS

Stifel analyst Stanley Elliott initiates coverage on Tecnoglass (NYSE:TGLS) with a Buy rating and announces a price target of $60.

Portfolio Pulse from richadhand@benzinga.com

June 15, 2023 | 10:26 am

ORGO

Morgan Stanley analyst Drew Ranieri initiates coverage on Organogenesis Holdings (NASDAQ:ORGO) with an Equal-Weight rating and a price target of $5.

Portfolio Pulse from richadhand@benzinga.com

June 15, 2023 | 10:25 am

ZION

Janney Montgomery Scott analyst Timothy Coffey downgraded Zions Bancorp (NASDAQ:ZION) from Buy to Neutral and announced a $35 price target.

Portfolio Pulse from richadhand@benzinga.com

June 15, 2023 | 10:24 am

DOGEUSD

Crypto analyst Nicholas Merten predicts that Dogecoin (CRYPTO: DOGE) could rally by 95% by late 2023 or early 2024, with smart money accumulation beginning when the memecoin is 95% from its all-time high. However, Merten warns of significant declines before an upward rally.

Portfolio Pulse from Mehab Qureshi

June 15, 2023 | 10:23 am

SOFI

Oppenheimer analyst Dominick Gabriele downgraded SoFi Techs (NASDAQ:SOFI) from Outperform to Perform.

Portfolio Pulse from richadhand@benzinga.com

June 15, 2023 | 10:23 am

ESPR

B of A Securities analyst Jason Zemansky upgraded Esperion Therapeutics (NASDAQ:ESPR) from Underperform to Buy and raised the price target from $1.25 to $4.

Portfolio Pulse from richadhand@benzinga.com

June 15, 2023 | 10:21 am

KSS

TD Cowen analyst Oliver Chen upgrades Kohl's (NYSE:KSS) from Market Perform to Outperform and raises the price target from $23 to $30.

Portfolio Pulse from richadhand@benzinga.com

June 15, 2023 | 10:19 am